Table 1.
Total patients (n = 73) | Initial surgery (n = 48) | Reoperation (n = 25) | p value | |
---|---|---|---|---|
Gender (n) | ||||
Male | 34 | 24 | 10 | 0.520 |
Female | 39 | 24 | 15 | |
Age (y) median (range) | 43 (14–90) | 42.5 (14–66) | 44 (21–90) | 0.709 |
Hospitalization time (d) mean ± SD | 10.6 ± 5.1 | 10.5 ± 5.4 | 10.8 ± 4.8 | 0.849 |
Approaches of MLND | ||||
Transcervical | 70 | 46 | 24 | 0.973 |
Transsternal | 3 | 2 | 1 | |
Follow-up time (m) mean (range) | 42.8 (12–101) | 39.4 (12–101) | 46.9 (12–86) | 0.246 |
Histopathology (n) | ||||
PTC | 60 | 47 | 13 | 0.658 |
MTC | 12 | 0 | 12 | |
ATC | 1 | 1 | 0 | |
Prognosis n (%) | 1.000 | |||
Disease-free | 53 (72.6) | 35 (72.9) | 18 (72.0) | |
Recurrence | 15 (20.5) | 11 (22.9) | 4 (16.0) | |
Distant metastasis | 4 (5.5) | 3 (6.3) | 1 (4.0) | |
Death | 5 (6.8) | 3 (6.3) | 2 (8.0) | |
Disease-specific death | 3 (4.1) | 2 (4.2) | 1 (4.0) |
PTC: papillary thyroid carcinoma; MTC: medullary thyroid carcinoma; ATC: anaplastic thyroid carcinoma; SD: standard deviation; MLNM: mediastinal lymph node metastases.